Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-18-000030

President and CEO sold 35,000 shares at an average $125.24 ($4,383,460)

From the SEC's structured data for this filing

Trades in this filing

Luly Jay R. · President and CEO

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2018-07-05 Sale : show line 1 in the form −2,977 $123.81 $368,568 625,049 D
2018-07-06 Sale : show line 2 in the form −12,622 $124.26 $1,568,460 612,427 D
2018-07-06 Sale : show line 3 in the form −7,538 $125.27 $944,265 604,889 D
2018-07-06 Sale : show line 4 in the form −7,738 $126.36 $977,788 597,151 D
2018-07-06 Sale : show line 5 in the form −4,125 $127.12 $524,379 593,026 D
Open-market sales · 35,000 sh · avg $125.24 · $4,383,460
Loading xslF345X03/edgar.xml…